Items where authors include "Black, C.J."

Article

Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2025) The case for reducing the use of diagnostic upper and lower gastrointestinal endoscopy. The Lancet Gastroenterology & Hepatology, 10 (4). pp. 285-287. ISSN 2468-1253

Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2024) Personalisation of therapy in irritable bowel syndrome: a hypothesis. The Lancet Gastroenterology & Hepatology, 9 (12). pp. 1162-1176. ISSN 2468-1253

Din, S., Segal, J., Blackwell, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). p1020-p1029. ISSN 2468-1156

Goodoory, V.C., Riggott, C., Khasawneh, M. et al. (2 more authors) (2024) Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Alimentary Pharmacology and Therapeutics. ISSN 0269-2813

Goodoory, V.C., Khasawneh, M., Thakur, E.R. et al. (9 more authors) (2024) Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis. Gastroenterology, 167 (5). p934-943.e5. ISSN 0016-5085

Gros, B., Blackwell, J., Segal, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). pp. 1030-1040. ISSN 2468-1156

Goodoory, V.C., Khasawneh, M., Black, C.J. et al. (1 more author) (2024) Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 22 (9). pp. 1942-1943. ISSN 1542-3565

Khasawneh, M., Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2024) Efficacy of Drugs Acting on Histamine 1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Gastroenterology, 167 (2). 400-401.e3. ISSN 0016-5085

Black, C.J., Houghton, L.A. orcid.org/0000-0002-5351-0229, West, R.M. orcid.org/0000-0001-7305-3654 et al. (4 more authors) (2024) Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population. Clinical Gastroenterology and Hepatology. ISSN 1542-3565

Khasawneh, M., Shaikh, F.A., Ng, C.E. et al. (3 more authors) (2024) Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterology & Motility. e14756. ISSN 1350-1925

Goodoory, V.C. orcid.org/0000-0001-9483-5604, Tuteja, A.K., Black, C.J. et al. (1 more author) (2024) Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 22 (2). E5. pp. 243-251. ISSN 1542-3565

Barberio, B., Gracie, D.J., Black, C.J. et al. (1 more author) (2024) Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis. Digestive and Liver Disease, 56 (1). pp. 7-14. ISSN 1590-8658

Khasawneh, M., Craig, O.F., Gracie, D.J. et al. (2 more authors) (2023) A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care. Clinical Gastroenterology and Hepatology, 21 (13). pp. 3397-3404. ISSN 1542-3565

Goodoory, V.C., Khasawneh, M., Black, C.J. et al. (3 more authors) (2023) Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology, 165 (5). pp. 1206-1218. ISSN 0016-5085

Visaggi, P. orcid.org/0000-0002-6985-5301, Barberio, B., Del Corso, G. et al. (4 more authors) (2023) Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis. Gut, 72 (11). pp. 2019-2030. ISSN 0017-5749

Riggott, C. orcid.org/0000-0002-6927-9498, Fairbrass, K.M. orcid.org/0000-0002-5569-4762, Black, C.J. orcid.org/0000-0001-5449-3603 et al. (2 more authors) (2023) Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study. Alimentary Pharmacology & Therapeutics. ISSN 0269-2813

Chuah, K. orcid.org/0000-0001-9811-7546, Black, C.J. orcid.org/0000-0001-5449-3603, Tee, V. orcid.org/0000-0002-6562-2666 et al. (6 more authors) (2023) A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care. Alimentary Pharmacology and Therapeutics, 58 (2). pp. 168-174. ISSN 0269-2813

Jaafari, H., Houghton, L.A. orcid.org/0000-0002-5351-0229, West, R.M. et al. (13 more authors) (2023) The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: results from the Rome foundation global epidemiology study. Neurogastroenterology & Motility, 35 (6). e14574. ISSN 1365-2982

Rej, A., Avery, A., Aziz, I. orcid.org/0000-0003-4313-0553 et al. (9 more authors) (2022) Diet and irritable bowel syndrome: an update from a UK consensus meeting. BMC Medicine, 20 (1). 287. ISSN 1741-7015

Black, C.J., Paine, P.A., Agrawal, A. et al. (10 more authors) (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut, 71 (9). pp. 1697-1723. ISSN 0017-5749